The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Calicheamicin γ 1 I : an Antitumor Antibiotic That Cleaves Double-Stranded DNA Site Specifically
Abstract
Calicheamicin γ 1 I is a recently discovered diyne-ene—containing antitumor antibiotic with considerable potency against murine tumors. In vitro, this drug interacts with double-helical DNA in the minor groove and causes site-specific double-stranded cleavage. It is proposed that the observed cleavage specificity is a result of a unique fit of the drug and DNA followed by the generation of a nondiffusible 1,4-dehydrobenzene—diradical species that initiates oxidative strand scission by hydrogen abstraction on the deoxyribose ring. The ability of calicheamicin γ 1 I to cause double-strand cuts at very low concentrations may account for its potent antitumor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Structure of a B-DNA dodecamer
Dickerson, R. E., & Drew, H. R. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90357-0 · Cited by 894
The molecular origin of DNA-drug specificity in netropsin and distamycin.
Kopka, M. L., Yoon, C. N., Goodsell, D. S., et al. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.5.1376 · Cited by 817
Lee, M. D., Dunne, T. S., Chang, C. C., Ellestad, G. A., Siegel, M. M., Morton, G. O., McGahren, W. J., & Borders, D. B. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00245a051 · Cited by 523
Self-citationLee, M. D., Dunne, T. S., Siegel, M. M., Chang, C. C., Morton, G. O., & Borders, D. B. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00245a050 · Cited by 392
Esperamicins, a novel class of potent antitumor antibiotics. 2. Structure of esperamicin X
Golik, J., Clardy, J., Dubay, G., Groenewold, G., Kawaguchi, H., Konishi, M., Krishnan, B., Ohkuma, H., Saitoh, K., & Doyle, T. W. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00245a048 · Cited by 272
Myers, A. G. (1987) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)96545-6 · Cited by 226
Synthesis of a Sequence-Specific DNA-Cleaving Peptide
Sluka, J. P., Horvath, S. J., Bruist, M. F., Simon, M. I., & Dervan, P. B. (1987) · Science · doi:10.1126/science.3120311 · Cited by 133
Kappen, L. S., & GOLDBERG, I. H. (1983) · Biochemistry · doi:10.1021/bi00290a002 · Cited by 105
Free radical mechanisms in neocarzinostatin-induced DNA damage.
Goldberg, I. H. (1987) · Free Radical Biology & Medicine · doi:10.1016/0891-5849(87)90038-4 · Cited by 79
Cited by
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Fu, Z., Li, S., Han, S., Shi, C., & Zhang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00947-7 · Cited by 1,643
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
Kantarjian, H. M., DeAngelo, D. J., Stelljes, M., Martinelli, G., Liedtke, M., Stock, W., Gökbuget, N., O’Brien, S., Wang, K., Wang, T., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509277 · Cited by 1,413
Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy
Chari, R. V. J., Miller, M. L., & Widdison, W. C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307628 · Cited by 930
A Comprehensive History of Arynes in Natural Product Total Synthesis
Tadross, P. M., & Stoltz, B. M. (2012) · Chemical Reviews · doi:10.1021/cr200478h · Cited by 873
Seebach, D. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199013201 · Cited by 577
Sievers, E. L., Appelbaum, F. R., Spielberger, R. T., Forman, S. J., Flowers, D., Smith, F. O., Shannon-Dorcy, K., Berger, M. S., & Bernstein, I. D. (1999) · Blood · doi:10.1182/blood.v93.11.3678 · Cited by 512
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
Povirk, L. F. (1996) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(96)00023-1 · Cited by 431
Carbon—Hydrogen Bonds of DNA Sugar Units as Targets for Chemical Nucleases and Drugs
Pratviel, G., Bernadou, J., & Meunier, B. (1995) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199507461 · Cited by 422
Smith, A. L., & Nicolaou, K. C. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9600398 · Cited by 377
DiJoseph, J. F., Armellino, D. C., Boghaert, E. R., Khandke, K., Dougher, M. M., Sridharan, L., Kunz, A., Hamann, P. R., Gorovits, B., Udata, C., et al. (2004) · Blood · doi:10.1182/blood-2003-07-2466 · Cited by 361
van der Velden, V. H. J., te Marvelde, J. G., Hoogeveen, P. G., Bernstein, I. D., Houtsmuller, A. B., Berger, M. S., & van Dongen, J. J. M. (2001) · Blood · doi:10.1182/blood.v97.10.3197 · Cited by 338
Advani, A., Coiffier, B., Czuczman, M. S., Dreyling, M., Foran, J., Gine, E., Gisselbrecht, C., Ketterer, N., Nasta, S., Rohatiner, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.1900 · Cited by 336
Ricart, A. D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0486 · Cited by 332
Role of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity
Walgren, J. L., Mitchell, M. D., & Thompson, D. C. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590935620 · Cited by 322
Goldberg, I. H. (1991) · Accounts of Chemical Research · doi:10.1021/ar00007a001 · Cited by 320
Antibody Drug Conjugates for Cancer Therapy
Polakis, P. (2016) · Pharmacological Reviews · doi:10.1124/pr.114.009373 · Cited by 307
Dynemicin A, a novel antibiotic with the anthraquinone and 1,5-diyn-3-ene subunit.
KONISHI, M., OHKUMA, H., MATSUMOTO, K., TSUNO, T., KAMEI, H., MIYAKI, T., OKI, T., KAWAGUCHI, H., VANDUYNE, G. D., & CLARDY, J. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.1449 · Cited by 301
The Calicheamicin Gene Cluster and Its Iterative Type I Enediyne PKS
Ahlert, J., Shepard, E., Lomovskaya, N., Zazopoulos, E., Staffa, A., Bachmann, B. O., Huang, K., Fonstein, L., Czisny, A., Whitwam, R. E., et al. (2002) · Science · doi:10.1126/science.1072105 · Cited by 292
Giles, F. J., Kantarjian, H. M., Kornblau, S. M., Thomas, D. A., Garcia-Manero, G., Waddelow, T. A., David, C. L., Phan, A. T., Colburn, D. E., Rashid, A., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010715)92:2<406::aid-cncr1336>3.0.co;2-u · Cited by 283
Antibody–drug conjugates: Recent advances in payloads
Wang, Z., Li, H., Gou, L., Li, W., & Wang, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.06.015 · Cited by 264
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Zhao, Y., Short, N. J., Kantarjian, H. M., Chang, T.-C., Ghate, P. S., Qu, C., Macaron, W., Jain, N., Thakral, B., Phillips, A. H., et al. (2024) · Blood · doi:10.1182/blood.2024023930 · Cited by 41
Metadata
- Authors
- Zein, N., Sinha, A. M., McGahren, W. J., & Ellestad, G. A.
- Venue
- Science
- Published
- 1988-05-27
- Volume
- 240
- Issue
- 4856
- Pages
- 1198-1201
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2043873747
- Cited by
- 565
- References
- 11
- FWCI
- 29.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.